Five Hindutva activists held for attack on three including woman for selling bible

Bengaluru, Mar 13: District administration in Kalaburagi, where the first death in India due to COVID-19 was reported, has identified over 25 people, who come close to the deceased and quarantined for observation, Minister for Health B Sreeramulu said on Friday.

In reply to a debate on the issue during Zero Hour of the Legislative Assembly, the Health Minister said that two members of the victim’s family and 23 others are suspected of COVID-19.

Mr. Sreeramulu said all the schools of the district have been as a preventive measure to contain the deadly virus.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Bengaluru, Mar 11: DK Shivakumar has been appointed as the new president of the party's Karnataka unit, an official said on Wednesday.

"Congress president (Sonia Gandhi) has appointed D.K. Shivakumar as the president of the Karnataka Pradesh Congress Committee (KPCC)," said party's general secretary K.C. Venugopal in a statement from New Delhi.

Party's state unit leaders Eshwar Khandre, Satish Jharkiholi and Saleem Ahammed are the working presidents in the southern state.

"Former chief minister Siddaramaiah will continue as the Congress Legislature Party (CLP) leader and opposition leader in the state legislative assembly.

MLC M. Narayanswamy and MLA Ajay Singh will be the party's chief whips in the state legislative council and assembly.

Congress appoints Anil Chaudhary as DPCC chief

The Congress on Wednesday appointed former MLA Anil Chaudhary as its Delhi unit chief, while also naming five vice-presidents for the DPCC.

Congress president Sonia Gandhi named Chaudhary president and Abhishek Dutt, Shivani Chopra, Jaikishan, Mudit Agarwal and Ali Hassan vice-presidents of the Delhi Pradesh Congress Committee (DPCC), a party statement said.

Subhash Chopra had resigned as the Delhi Congress chief in February, taking moral responsibility for the party's debacle in the Assembly polls.

The Congress drew a blank for the second time in a row in the Delhi Assembly polls and reduced its vote share from 9.7 per cent in 2015 to 4.27 per cent this time.